Brilliant Violet 570™ anti-human CD45RO

Antibodies Single
Sony
UCHL1
Flow Cytometry
Mouse IgG2a, κ
Human
IL-2 dependent T cell line, CA1
2121125
$237.00

Description

CD45RO is a 180 kD single chain membrane glycoprotein. It is a splice variant of tyrosine phosphatase CD45, lacking the A, B, and C determinants. The CD45RO isoform is expressed on activated and memory T cells, some B cell subsets, activated monocytes/macrophages, and granulocytes. CD45RO enhances both T cell receptor and B cell receptor signaling mediated activation. CD45 and its isoforms non-covalently associate with lymphocyte phosphatase-associated phosphoprotein (LPAP) on T and B lymphocytes. CD45 has been reported to be associated with several other cell surface antigens including CD1, CD2, CD3, and CD4. CD45 has also been reported to bind galectin-1 and CD22. CD45 isoform expression can change in response to cytokines.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤5 microL per million cells or 5 microL per 100 microL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 570™ excites at 405 nm and emits at 570 nm. The bandpass filter 585/42 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 570™ is a trademark of Sirigen Group Ltd.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

References

1. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York. (FC)
2. Ishii T, et al. 2001. P. Natl. Acad. Sci. USA 98:12138. (WB)
3. Ponsford M, et al. 2001. Clin. Exp. Immunol. 124:315. (IP)
4. Yamada M, et al. 1996. Stroke 27:1155. (IHC)
5. Sakkas LI, et al. 1998. Clin. Diagn. Lab. Immunol. 5:430. (IHC)
6. Baba N, et al. 2010. Int. Immunol. 22:237. PubMed
7. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
8. Weiss L, et al. 2010. P. Natl. Acad. Sci. USA 107:10632. PubMed
9. Wu YY, et al. 2007. Infect. Immun. 75:4357. PubMed
10. Mozaffarian N, et al. 2008. Rheumatology 47:1335. PubMed
11. Roque S, et al. 2007. J. Immunol. 178:8028. PubMed
12. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
13. Smith SH, et al. 1986. Immunology 58:63. (Immunogen)